February 13, 2020

FDA Clears BD's Caterpillar Embolization Devices

February 13, 2020—BD Peripheral Intervention, Inc. announced FDA clearance of the Caterpillar arterial embolization device and the Caterpillar micro arterial embolization devices.

According to the company, the Caterpillar devices utilize a dual-action design with opposing nitinol fiber segments and an occlusion membrane.

BD notes that the devices are available in the United States in three sizes to treat target artery diameters ranging from 1.5 mm to 7 mm.

The Caterpillar and Caterpillar micro arterial embolization devices are indicated for arterial embolization in the peripheral vasculature. The devices are contraindicated for use in vessels subject to cyclic bending, such as locomotive joints or muscle beds.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

February 13, 2020

FDA Clears BD's Caterpillar Embolization Devices

Current Issue

Keep In Touch